pandora-id

Coronavirus publications

1. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish ZA, Drosten C, Zumla A, Petersen E.

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Int J Infect Dis.2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14. PMID: 31953166

2. Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M.

Reducing mortality from 2019-nCoV: host-directed therapies should be an option. 

Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5. PMID: 32035018 

3. Kock RA, Karesh WB, Veas F, Velavan TP, Simons D, Mboera LEG, Dar O, Arruda LB, Zumla A.

2019 -nCoV in context: lessons learned?

Lancet Planet Health. 2020 Feb 6. pii: S2542-5196(20)30035-8. doi: 10.1016/S2542-5196(20)30035-8. [Epub ahead of print]. PMID: 32035507 

4. Ippolito G, Huis DS, Ntoumi F, Maeurer M, Zumla A.

Toning down the 2019-nCoV media hype—and restoring hope.

Lancet Respir Med. 2020 Mar;8(3):230-231. doi: 10.1016/S2213-2600(20)30070-9. Epub 2020 Feb 12. PMID: 32146924

5. Memish ZA, Perlman S, Van Kerkhove MD, Zumla A.

Middle East respiratory syndrome.

Lancet. 2020 Mar 4. pii: S0140-6736(19)33221-0. doi: 10.1016/S0140-6736(19)33221-0. [Epub ahead of print]. PMID: 32145185

6. Haider N, Yavlinsky A, Simons D, Osman AY, Ntoumi F, Zumla A, Kock R.

Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America. 

Epidemiol Infect. 2020;148:e41. Published 2020 Feb 26. doi:10.1017/S0950268820000424. PMID: 32100667

7. Kapata N, Ihekweazu C, Ntoumi F, Tajudeen R, Chanda-Kapata P, Mwaba P, Mukonka V, Bates M, Tembo J, Corman V, MfinangaS, AsogunD, Elton L, Arruda LB, Thomason MJ, Mboera L, YavlinskyA, Haider N, Simons D, Hollmann L, Lule SA, Veas F, Hamid MMA, Dar O, EdwardsSJL, Vairo F, McHugh TD, Drosten C, KockR, Ippolito G, Zumla A.

Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future

Int J Infect Dis. 2020 Feb 28. pii: S1201-9712(20)30107-7. doi: 10.1016/j.ijid.2020.02.049. [Epub ahead of print]. PMID: 3211998

8. Velavan TP, Meyer CG.

The COVID‐19 epidemic.

Trop Med IntHealth.2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.PMID: 32052514

9. Petersen E, Hui D, Hamer D, Blumberg L, Madoff L, Pollack M, Lee SS, McLellan S, MemishZ, Praharaj I, Wasserman S, Ntoumi F, Azhar EA, McHugh TD, Kock R, Ippolito G, Zumla A, Koopmans M

Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.

Int J Infect Dis 2020 Mar 4;93:205-207. doi: 10.1016/j.ijid.2020.02.052. PMID: 32142979

10. Zumla A, Niederman MS.

The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security.

Curr Opin Pulm Med. 2020 Mar 5. doi: 10.1097/MCP.0000000000000676. [Epub ahead of print]. PMID: 32132379

11. Albarello F, Pianura E, Di Stefano F, Cristofaro M, Petrone A, Marchioni L, Palazzolo C, Schininà V, Nicastri E, Petrosillo N, Campioni P, Petersen E, Zumla A, Ippolito G, COVID 19 INMI Study Group.

2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation [published online ahead of print, 2020 Feb 26].

Int J Infect Dis. 2020 Feb 26;93:192-197. doi: 10.1016/j.ijid.2020.02.043. [Epub ahead of print]. PMID: 32112966

12. McCloskey B, Zumla A, Ippolito G, Blumberg L, Arbon P, Cicero A, Endericks T, Lim PL, Borodina M, on behalf of the WHO Novel Coronavirus-19 Mass Gatherings Expert Group

Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma.

Lancet. 2020 doi:10.1016/S0140-6736(20)30681-4. Epub 2020 Mar 20.PMID: 32203693

13. Chanda-Kapata P, Kapata N, Zumla A,

COVID-19 and malaria: A symptom screening challenge for malaria endemic countries.

Int J Infect Dis. 2020 Apr 25;94:151-153. doi: 10.1016/j.ijid.2020.04.007. PMID: 32344326

14. Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, Sam-Agudu NA, Muyembe TamFum JJ, Seydi M, Eholie SP, Mills EJ, Kallay O, Zumla A, Nachega JB. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings

Am J Trop Med Hyg. 2020 Apr 22. doi: 10.4269/ajtmh.20-0290. Online ahead of print.

PMID: 32323646

15. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

Cell Stress. 2020 Mar 2;4(4):66-75. doi: 10.15698/cst2020.04.216. PMID: 32292881

16.Petersen E, McCloskey B, Hui DS, Kock R, Ntoumi F, Memish ZA, Kapata N, Azhar EI, Pollack M, Madoff LC, Hamer DH, Nachega JB, Pshenichnaya N, Zumla A

COVID-19 travel restrictions and the International Health Regulations - Call for an open debate on easing of travel restrictions.

Int J Infect Dis. 2020 Apr 17;94:88-90. doi: 10.1016/j.ijid.2020.04.029. PMID: 32305518 

17. McCloskey B, Zumla A, Lim PL, Endericks T, Arbon P, Cicero A, Borodina M

A risk-based approach is best for decision making on holding mass gathering events.

Lancet. 2020 Apr 18;395(10232):1256-1257. doi: 10.1016/S0140-6736(20)30794-7. Epub 2020 Apr 2. PMID: 32247321

18. Nachega JB, Seydi M, Zumla A.

The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread [published online ahead of print, 2020].

Clin Infect Dis. 2020; ciaa353. doi:10.1093/cid/ciaa353 https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa353/5813601

19.Dexter D, Simons D, Kiyaga C, Kapata N, Ntoumi F, Kock R, Zumla A

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries

Lancet Haematol. 2020 Apr 23:S2352-3026(20)30122-8. doi: 10.1016/S2352-3026(20)30122-8. Online ahead of print. PMID: 32334676

20. Shaheen Mehtar,Wolfgang Preiser,Ndèye Aissatou Lakhe,Abdoulaye Bousso,Jean-Jacques Muyembe TamFum,Oscar Kallay,Moussa Seydi,Alimuddin Zumla,Jean B Nachega.

Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries.

Lancet Global Health. 2020. April 28, 2020. DOI:https://doi.org/10.1016/S2214-109X(20)30212-6.

21. Velavan TP and Meyer CG.

Mild vs. Severe COVID19: Laboratory markers,

Int J Infect Dis. 2020 Apr 25. pii: S1201-9712(20)30277-0. doi: 10.1016/j.ijid.2020.04.061. PMID: 32344011.

22. Nachega JB, Leisegang R, Kallay O, Mills EJ, Zumla A, Lester RT.

Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?

Am J Trop Med Hyg. 2020 May 29. doi: 10.4269/ajtmh.20-0506. Online ahead of print. PMID: 32476643

23. Nachega JB, Grimwood A, Mahomed H, Fatti G, Preiser W, Kallay O, Mbala PK, Muyembe JT, Rwagasore E, Nsanzimana S, Ngamije D, Condo J, Sidat M, Noormahomed EV, Reid M, Lukeni B, Suleman F, Mteta A, Zumla A.

From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.

Clin Infect Dis. 2020 May 31:ciaa695. doi: 10.1093/cid/ciaa695. Online ahead of print. PMID: 32474594

24. Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G.

1COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

J Intern Med. 2020 May 27:10.1111/joim.13101. doi: 10.1111/joim.13101.

PMID: 32459372

25. Carsetti R, Quintarelli C, Quinti I, Piano Mortari E, Zumla A, Ippolito G, Locatelli F. The immune system of children: the key to understanding SARS-CoV-2 susceptibility?

Lancet Child Adolesc Health. 2020 Jun;4(6):414-416. doi: 10.1016/S2352-4642(20)30135-8. Epub 2020 May 6.PMID: 3245880

26. Messina F, Giombini E, Agrati C, Vairo F, Ascoli Bartoli T, Al Moghazi S, Piacentini M, Locatelli F, Kobinger G, Maeurer M, Zumla A, Capobianchi MR, Lauria FN, Ippolito G; COVID 19 INMI Network Study Group.

COVID-19: Viral-Host Interactome Analyzed by Network Based-Approach Model to Study Pathogenesis of SARS-CoV-2 Infection

J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w. PMID: 32522207

27. Gualano G, Musso M, Mosti S, Mencarini P, Mastrobattista A, Pareo C, Zaccarelli M, Migliorisi P, Vittozzi P, Zumla A, Ippolito G, Palmieri F.

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report.

Int J Infect Dis. 2020 May 10:S1201-9712(20)30334-9. doi: 10.1016/j.ijid.2020.05.027. Online ahead of print. PMID: 32437932

28. Zumla A, Wang FS, Ippolito G, Petrosillo N, Agrati C, Azhar EI, El-Kafrawy SA, Osman M, Zitvogel L, Locatelli F, Gorman E, O'Kane C, Mcauley D, Maeurer M.

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies.

Int J Infect Dis. 2020 May 17. doi: 10.1016/j.ijid.2020.05.040. Online ahead of print. PMID: 32425638

29. Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, Casetti R, Giancola L, Bevilacqua N, Maeurer M, Zumla A, Locatelli F, De Benedetti F, Palmieri F, Marchioni L, Capobianchi MR, D'Offizi G, Petrosillo N, Antinori A, Nicastri E, Ippolito G, Agrati C.

An Inflammatory Profile Correlates with Decreased Frequency of Cytotoxic Cells in COVID-19.

Clinical Infectious Diseases. 2020 May 15:ciaa577. doi: 10.1093/cid/ciaa577. Online ahead of print. PMID: 32407466

30. Agrati C, Sacchi A, Bordoni V, Cimini E, Notari S, Grassi G, Casetti R, Tartaglia E, Lalle E, D'Abramo A, Castilletti C, Marchioni L, Shi Y, Mariano A, Song JW, Zhang JY, Wang Fu-S, Zhang C, Fimia GM, Capobianchi MR, Piacentini M, Antinori A, Nicastri E, Maeurer M, Zumla A, Ippolito G.

Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).

Cell Death Differ. 2020 Jun 8:1-12. doi: 10.1038/s41418-020-0572-6. Online ahead of print.PMID: 32514047

Non-Covid publications

31. Mukonzo JK, Kengo A, Kutesa B, Nanzigu S, Pohanka A, McHugh TD, ZumlaA, Aklillu E.

Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients. 

Trans R Soc Trop Med Hyg. 2020 Feb 7;114(2):107-114. doi: 10.1093/trstmh/trz108.PMID: 31789383

32. Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M, Vorster M, Saranovic DS, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB; ;

International Atomic Energy Agency Extra-pulmonary TB Consortium.

PET/CT features of extrapulmonary tuberculosis at first clinical presentation: a cross-sectional observational 18F-FDG imaging study across six countries. 

Eur Respir J.2020 Feb 27;55(2). pii: 1901959. doi: 10.1183/13993003.01959-2019. Print 2020 Feb. PMID: 31831584

33. Chakaya JM, Marais B, du Cros P, Ntoumi F, Mfinanga S, Kapata N, Hasnain SE, Nathavitharana R, Zumla A.

Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis.

Lancet Respir Med. 2020 Feb 27. pii: S2213-2600(20)30104-1. doi: 10.1016/S2213-2600(20)30104-1. [Epub ahead of print]. PMID: 32113573

34. Petersen E, Memish ZA, Zumla A, Maani AA.

Transmission of respiratory tract infections at mass gathering events.

Curr Opin Pulm Med. 2020 Mar 5. doi: 10.1097/MCP.0000000000000675. [Epub ahead of print]. PMID: 32149751

35. Tiberi S, Migliori G-B, Chakaya JM, Kaesava T, Al Abri SS, Wejse C, Goletti D, Kapata N, Sotgiu G, Bomanji J , Zellweger J-P, Hasan R, Irfan M, Ahmed I, Pshenichnaya N, Vasilieva I, Yeboah-Manu D, Alffenaar J-W, Kim HY, Centis R, Cirillo DM, Alagna R, D'Ambrosio L, Maeurer M, Cui X, Cao B, Harries AD, Al Abri S, Raviglione M, Zumla A, Petersen E, Ippolito G.

Commemorating World TB Day 2020: "IT'S TIME" - It's Time to End the Global TB Epidemic.

Int J Infect Dis. 2020 Mar 4. pii: S1201-9712(20)30120-X. doi: 10.1016/j.ijid.PMID: 32145464

36.. Marais BJ, Amanullah F, Gupta A, Becerra MC, Snow K, Ngadaya E, Sharma M, Hesseling AC, Chakaya M, Zumla A.

Tuberculosis in children, adolescents, and women.

Lancet Respir Med. 2020 Feb 27. pii: S2213-2600(20)30077-1. PMID: 32113571

37.. Zumla A, Ippolito G, Ntoumi F, Seyfert-Margolies V, Nagu TJ, Cirillo D, Chakaya JM, Marais B, Maeurer M.

Host-directed therapies and holistic care for tuberculosis.

Lancet Respir Med.2020 Feb 27. pii: S2213-2600(20)30078-3. PMID: 3211357

38. Mwaba P, Chakaya JM, Petersen E, Wejse C, Zumla A, Kapata N.

Advancing New diagnostic tests for Latent TB infection due multi-drug resistant strains of Mycobacterium tuberculosis - End of the road?

Int J Infect Dis. 2020 Feb 28. pii: S1201-9712(20)30069-2. doi: 10.1016/j.ijid.2020.02.011. [Epub ahead of print]. PMID: 32119979

39. Priftakis D, Riaz S, Zumla A, Bomanji J.

Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in active and latent tuberculosis.

Int J Infect Dis. 2020 Feb 27. pii: S1201-9712(20)30075-8. doi: 10.1016/j.ijid.2020.02.017. [Epub ahead of print]. PMID: 32114199

40. Ihekweazu C, Yinka-Ogunleye A, Lule S, Ibrahim A.

Importance of epidemiological research of monkeypox: is incidence increasing?

Expert Rev Anti Infect Ther. 2020 Mar 2:1-4. doi: 10.1080/14787210.2020.173PMID: 32096659

41. Yavlinsky A, Lule SA, Burns R, Zumla A, McHugh TD, Ntoumi F, Masanja H, Mwakasungula S, Abubakar I, Aldridge RW.

Mobile-based and open-source case detection and infectious disease outbreak management systems; a review.

Wellcome Open Res. 2020, 5:37 doi.org/10.12688/wellcomeopenres.15723.1

42. .Hsu D, Irfan M, Jabeen K, Iqbal N, Hasan R, Migliori GB, Zumla A, Visca D, Centis R, Tiberi S.

Post tuberculosis treatment infectious complications

Int J Infect Dis. 2020;S1201-9712(20)30090-4. doi:10.1016/j.ijid.2020.02.032. PMID: 32114203

43. Marais BJ, Chakaya J, Swaminathan S, Fox GJ, Ehtesham NZ, Ntoumi F, Maeurer M, Zumla A.

Tackling long-term morbidity and mortality after successful tuberculosis treatment [published online ahead of print, 2020 Mar 23].

Lancet Infect Dis. 2020; S1473-3099(20)30167-5. doi:10.1016/S1473-3099(20)30167-5. PMID: 32213333

44. Zumla A, Yeboah-Manu D, Michel AL, Azhar EI, Torrelles JB, Cadmus SI, Kendall SL, Chakaya JM, Marais B, Kock R.

Zoonotic tuberculosis-a call for an open One Health debate [published online ahead of print, 2020 Mar 23].

Lancet Infect Dis. 2020;S1473- 3099(20)30166-3. doi:10.1016/S1473-3099(20)30166-3. PMID: 32213331

45. Sahu S, Ditiu L, Lawson L, Ntoumi F, Arakaki D, Zumla A.

UN General Assembly tuberculosistargets: are we on track?.

Lancet. 2020;395(10228):928–930. doi:10.1016/S0140-6736(20)30565-1. PMID: 32199477

46. Simulundu E, Ndashe K,Chambaro HM, Squarre D,Reilly PM, Chitanga S,Changula K, Mukubesa AN,Ndebe J, Tembo J, Kapata N, Bates M, Sinkala Y,Hang’ombe BM, Nalubamba KS, Kajihara M, Sasaki M, Orba Y, Takada A, Sawa H.

West Nile Virus in Farmed Crocodiles, Zambia, 2019.

Emerg Infect Dis. 2020 Apr;26(4):811-814. doi: 10.3201/eid2604.190954.PMID: 32187004

1. Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo — Progress, obstacles and challenges in HIV/ AIDS health services Int J Infect Dis. 2018;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17. PMID: 30342250
   
2. Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, Chakaya J, Zumla A, Ippolito G Tuberculin skin test – Outdated or still useful for Latent TB infection screening? Int J Infect Dis. 2019; 80S:S20-S22 DOI: 10.1016/j.ijid.2019.01.048. PMID:30738186
3. Honeyborne I, Lipman M, Zumla A, McHugh TD The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world? Int J Infect Dis. 2019; Mar;80S:S23-S28. doi: 10.1016/j.ijid.2019.02.006. Epub 2019 Feb 15. PMID: 30776547
4. Kock RA, Haider N, Mboera LEG, Zumla A. A One-Health lens for anthrax. Lancet Planet Health. 2019 Jul;3(7):e285-e286. doi: 10.1016/S2542-5196(19)30111-1. PMID: 31326067
   
5. Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.  Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis. 2019; Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review. PMID: 30453097
   
6. Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M. Latent TB Infection (LTBI) – Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. Int J Infect Dis. 2019 Mar; 80S:S58-S61. doi: 10.1016/j.ijid.2019.02.035. Epub 2019 Feb 26. PMID: 30822547
   
7. Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M. Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future. Int J Infect Dis. 2019; 80S: Mar;80S:S62-S67. doi: 10.1016/j.ijid.2019.01.039. Epub 2019 Jan 24. PMID:30685590
   
8. Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G, Zumla A, Bates M. Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn. 2019 Apr;19(4):325-340. doi: 10.1080/14737159.2019.1595592. Epub 2019 Apr 5. PMID: 30916590
   
9. Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-598. doi: 10.1038/s41585-019-0228-9. PMID: 31548730
   
10. Lanini S, Ioannidis JPA, Vairo F, Pletschette M, Portella G, Di Bari V, Mammone A, Pisapia R, Merler S, Nguhuni B, Langer M, Di Caro A, Edwards SJL, Petrosillo N, Zumla A, Ippolito G. Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.Lancet Infect Dis. 2019 Aug 23. pii: S1473-3099(19)30284-1. doi: 10.1016/S1473-3099(19)30284-1. PMID: 31451421
    
11. Lalle E, Biava M, Nicastri E, Colavita F, Di Caro A, Vairo F, Lanini S, Castilletti C, Langer M, Zumla A, Kobinger G, Capobianchi MR, Ippolito G. Pulmonary Involvement during the Ebola Virus Disease. Viruses. 2019 Aug 24;11(9). pii: E780. doi: 10.3390/v11090780. PMID: 3145059
    
12. Zumla A, Memish ZA. Risk of antibiotic resistant meningococcal infections in Hajj pilgrims. BMJ. 2019 Aug 23;366:l5260. doi: 10.1136/bmj.l5260. PMID: 31444169.
    
13. Perlman S, Azhar EI, Memish ZA, Hui DS, Zumla A. Confronting the persisting threat of the Middle East respiratory syndrome to global health security.
    
14. Lancet Infect Dis. 2019 Jul 3. pii: S1473-3099(19)30347-0. doi: 10.1016/S1473-3099(19)30347-0. PMID: 31279728
    
15. Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, Zumla A. Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events. Lancet. 2019 May 18;393(10185):2073-2084. doi: 10.1016/S0140-6736(19)30501-X. PMID: 31106753
    
16. Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya - Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.
    
17. Infect Dis Clin North Am. 2019 Dec;33(4):1003-1025. doi: 10.1016/j.idc.2019.08.006. PMID: 31668189.
    
18. Nicastri E, Kobinger G, Vairo F, Montaldo C, Mboera L, Ansunama R, Zumla A, Ippolito G. Ebola Virus Disease - Epidemiology, Clinical Features, Management, and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):953-976. doi: 10.1016/j.idc.2019.08.005. PMID: 31668200
    
19. Iannetta M, Di Caro A, Nicastri E, Vairo F, Masanja H, Kobinger G, Mirazimi A, Ntoumi F, Zumla A, Ippolito G. Viral Hemorrhagic Fevers Other than Ebola and Lassa. Infect Dis Clin N Am. 2019; 33: 977–10022019 Dec;33(4):977-1002. doi: 10.1016/j.idc.2019.08.003. PMID: 31668201
    
20. Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral Hepatitis - Etiology, Epidemiology, Transmission, Diagnostics, Treatment and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1045-1062.doi:10.1016/j.idc.2019.08.004. PMID:31668190
    
21. Asogun DA, Günther S, Akpede GO, Ihekweazu C, Zumla A. Lassa Fever - Epidemiology, Clinical Features, Diagnosis, Management and Prevention Infect Dis Clin N Am 2019; Dec;33(4):933-951. doi: 10.1016/j.idc.2019.08.002. PMID: 31668199
    
22. Zumla A, Hui DSC. Emerging and Re-emerging Infectious Diseases - Global Overview. Infect Dis Clin North Am. 2019 Dec;33(4):xiii-xix. doi: 10.1016/j.idc.2019.09.001. PMID: 31668202
    
23. Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East Respiratory Syndrome (MERS). Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001. PMID: 31668197
    
24. Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019 Dec;33(4):869-889. doi: 10.1016/j.idc.2019.07.001. PMID: 31668196
    
25. Tiberi S, Zumla A, Migliori GB. Multidrug and Extensively Drug-resistant Tuberculosis - Epidemiology, Clinical Features, Management and Treatment. Infect Dis Clin North Am. 2019 Dec;33(4):1063-1085. doi: 10.1016/j.idc.2019.09.002. PMID: 31668191
    
26. Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A. Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi: 10.1016/j.idc.2019.03.001. Epub 2019 Apr 11. PMID: 30981594
    
27. Mikounou VL, Nguekeng Tsague B, Ntoumi F, Vouvoungui C, Charles Kobawila S. 2019. High prevalence of norovirus and rotavirus co-infection in children with acute gastroenteritis hospitalized in Brazzaville, Republic of Congo. Tropical Medicine and International Health. 2019 Oct 18. doi: 10.1111/tmi.13317
    
28. Mikounou Louya V, Vouvoungui C, Koukouikila-Koussounda F, Veas F, Kobawila SC, Ntoumi F. Molecular characterization of norovirus infection responsible for acute diarrhea in Congolese hospitalized children under five years old in Brazzaville, Republic of Congo. Int J Infect Dis. 2019 Aug 2;88:41-48. doi: 10.1016/j.ijid.2019.07.034. [Epub ahead of print] PMID: 31382046
    
29. Ntoumi F. Supporting female scientists in Africa. Lancet. 2019 Jun 1;393(10187):2196. doi: 10.1016/S0140-6736(19)31105-5. PMID: 31162075
    
30. Peko SM, Ntoumi F, Vouvoungui C, Nderu D, Kobawila SC, Velavan TP, Koukouikila-Koussounda F. Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo. Int J Infect Dis. 2019 Aug;85:49-53. doi: 10.1016/j.ijid.2019.04.035. Epub 2019 May 9. PMID: 31078747
    
31. Mbouamboua Y, Koukouikila-Koussounda F, Ntoumi F, Adukpo S, Kombo M, Vouvoungui C, van Helden J, Kobawila SC. Sub-microscopic Plasmodium falciparum infections in matched peripheral, placental and umbilical cord blood samples from asymptomatic Congolese women at delivery. Acta Trop. 2019 May;193:142-147. doi: 10.1016/j.actatropica.2019.03.001. PMID: 30836060
    
32. Gampio Gueye NS, Peko SM, Nderu D, Koukouikila-Koussounda F, Vouvoungui C, Kobawila SC, Velavan TP, Ntoumi F. 2019. An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo. Malaria Journal. 2019 Feb 28;18(1):57. doi: 10.1186/s12936-019-2688-z. PMID: 30819192
    
33. Peko SM, Gueye NSG, Vouvoungui C, Koukouikila-Koussounda F, Kobawila SC, Nderu D, Velavan TP, Ntoumi F. Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection. Int J Infect Dis. 2019 May;82:111-116. doi: 10.1016/j.ijid.2019.02.025. Epub 2019 Feb 25. PMID: 30818046
    
34. Bomanji J, Rajnish Sharma, BhagwantR. Mittal, Sanjay Gambhir, Ahmad Qureshy, Shamim M.F. Begum, Diana Paez, Mike Sathekge, Mariza Vorster, Dragana Sobic Saranovic, Pawana Pusuwan, Vera Mann, Sobhan Vinjamuri, Alimuddin Zumla, Thomas N.B. Pascual for the International Atomic Energy Agency Extra-pulmonary TB Consortium PET/CT features of Extrapulmonary Tuberculosis at first clinical presentation - a cross-sectional observational 18F-FDG imaging study across six countries
    
35. European Respiratory Journal 2019; DOI: 10.1183/13993003.01959-2019
    
36. Jackson K Mukonzo, Allan Kengo, Bisaso Kutesa, Sarah Nanzigu, Anton Pohanka, Timothy D McHugh, Alimuddin Zumla, Eleni Aklillu. Role of Pharmacogenetics in Rifampicin Pharmacokinetics and the Potential Effect on TB-rifampicin Sensitivity Among Ugandan Patients Trans R Soc Trop Med Hyg 2019 Dec 2[Online ahead of print]
    
37. El-Kafrawy SA, Corman VM, Tolah AM, Saad B, Al Masaudi, Ahmed M Hassan, Marcel A Müller, Tobias Bleicker, Steve M Harakeh, Abdulrahman A Alzahrani , Ghaleb A Alsaaidi, Abdulaziz N Alagili , Anwar M Hashem, Alimuddin Zumla*, Christian Drosten*, Esam I Azhar*. *Contributed equally Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study. Lancet Planetary Health. 2019;3(12):e521–e528. doi:10.1016/S2542-5196(19)30243-8
    
38. Colavita F, Vairo F, Carletti F, Boccardo B, Ferraro F, Iaiani G, Al Moghazi S, Galardo G, Lalle E, Selvaggi C, Scognamiglio P, Capobianchi MR, Ippolito G, Castilletti C.
    
39. Full-Length Genome Sequence of a Dengue serotype 1 virus isolate from a traveller returning from Democratic Republic of Congo to Italy, July 2019. Int J Infect Dis. 2019;S1201-9712(19)30496-5. doi:10.1016/j.ijid.2019.12.023. Epub 2019 Dec 19.
    
40. 
    

1. Abubakar I, Zumla A. Universal health coverage for refugees and migrants in the twenty-first century. BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0. PMID: 30497477
   
2. Zumla A, Abubakar I. Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants. BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0. PMID: 30497477
   
3. Edwards SJL, Norell CH, Illari P, Clarke B, Neuhaus CP. A Radical Approach to Ebola: Saving Humans and Other Animals. Am J Bioeth. 2018;18(10):35-42